AlphaGenome, an artificial intelligence system just released by Google DeepMind in London, aims to show how even tiny changes ...

This AI system can analyze up to one million DNA letters at once, predicting how tiny changes in noncoding regions trigger ...

Google DeepMind CEO Demis Hassabis heads Gemini and the company's AI push while gaining more power. Here's how he became ...

Google has officially merged Bard with DeepMind’s cutting-edge research—and the result is a new era of AI capability. In this ...

The AI tools market is currently highly volatile; savvy enterprise customers might want to consider a multi-vendor approach, ...

Zuckerberg is picking off top talent from across the industry, and OpenAI might be more vulnerable than most.

This week in AI, DeepMind, the Google-owned AI R&D lab, released a paper proposing a framework for evaluating the societal and ethical risks of AI systems.

Nearly 200 DeepMind workers signed a letter urging Google to drop military contracts, fearing AI misuse and violations of the company’s own rules.

DeepMind’s clinical lead, Dominic King, hopes that using AI to predict patient deterioration would allow clinicians to intervene earlier. In the case of AKI, rehydration, antibiotics or altering ...